12/01/21 9:00 AMNasdaq : GOVX, GOVXW covid-19low floatGeoVax Presents COVID-19 Vaccine Data at the World Vaccine & Immunotherapy CongressGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancerRHEA-AIvery negative
11/17/21 9:00 AMNasdaq : GOVX, GOVXW covid-19low floatGeoVax Presents COVID-19 Vaccine Data at the Vaccine World Asia CongressGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, todayRHEA-AIneutral
11/16/21 9:00 AMNasdaq : GOVX, GOVXW low floatGeoVax Receives Notice of Allowance for Cancer Vaccine PatentGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseasesRHEA-AIvery positive
11/15/21 9:00 AMNasdaq : GOVX, GOVXW conferenceslow floatGeoVax Announces Upcoming Presentations at Scientific ConferencesGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, announced today that it will be represented during presentations at the following upcoming scientificRHEA-AIneutral
11/11/21 4:00 PMNasdaq : GOVX, GOVXW earningslow floatGeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate UpdateGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancers, today announcedRHEA-AIneutral
11/09/21 4:00 PMNasdaq : GOVX, GOVXW covid-19low floatGeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope's COVID-19 VaccineGeoVax Labs Inc. (Nasdaq: GOVX), a biotechnology company specializing in developingRHEA-AIvery positive
11/04/21 9:00 AMNasdaq : GOVX, GOVXW conferencesearningslow floatGeoVax to Report Third Quarter 2021 Financial Results on Thursday, November 11, 2021 and Provide Corporate UpdateGeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectiousRHEA-AIneutral
10/18/21 9:00 AMNasdaq : GOVX, GOVXW conferenceslow float GeoVax Chief Scientific Officer to Participate in World Vaccine Congress Europevia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that Mark J. Newman,RHEA-AIneutral
10/14/21 9:00 AMNasdaq : GOVX, GOVXW low floatGeoVax Receives Notice of Allowance for Ebola Vaccine PatentGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, todayRHEA-AIneutral
09/28/21 4:00 PMNasdaq : GOVX, GOVXW acquisitionlow floatGeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer ProgramGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancerRHEA-AIpositive
